Sanofi blockbuster drug wins clearance in US for lung disease
WEB5 hours ago · The FDA clearance comes as Sanofi Chief Executive Officer Paul Hudson looks to turn the French drugmaker into a global powerhouse with a slew of next-generation therapies.
Sanofi Blockbuster Drug Wins Clearance in US for Lung Disease
WEBThe FDA clearance comes as Sanofi Chief Executive Officer Paul Hudson looks to turn the French drugmaker into a global powerhouse with a slew of next-generation therapies. Hudson has increased ...
Sanofi CEO believes company poised for growth from new drugs
WEB4 days ago · NEW YORK, Sept 23 (Reuters) - Sanofi's (SASY.PA) chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not ...
Dupilumab Becomes First Biologic Approved in the US as Targeted …
WEB21 hours ago · September 27, 2024. By Grace Halsey. News. Article. Dupilumab represents the first new treatment approach for uncontrolled COPD in more than a decade and reduced disease exacerbations by 34% in clinical trials. Sanofi and Regeneron Pharmaceuticals announced today that the US FDA has approved the biologic dupilumab (Dupixent) as …
Sanofi CEO believes company poised for growth from new drugs
WEB4 days ago · NEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent, costly patent expirations of top-selling products as are some rivals. "We've spent five years as a team getting Sanofi to the start line of being a respected R&D machine, and I think the markets are ...
Sanofi chief says he could have done a better job outlining R&D …
WEBDec 7, 2023 · Sanofi chief executive Paul Hudson has admitted he could have done a better job explaining aspects of a multibillion-euro investment plan to shareholders, ahead of a meeting where he will try...
The secrets of success with Paul Hudson, CEO of Sanofi
WEBJun 20, 2024 · Forget expensive coaches, Paul Hudson, CEO of Sanofi turns to his three children for advice: ‘Through their eyes I get a glimpse into what the future looks like for the next generation’
Sanofi Enters Next Chapter of Play to Win Strategy | Sanofi
WEBOct 27, 2005 · Paul Hudson Chief Executive Officer, Sanofi “We have made tremendous progress on our Play to Win strategy by bringing new and transformative products to market and building an industry-leading immunology pipeline, evidenced by our recent, strong flow of positive R&D data readouts.
Sanofi “all in” on artificial intelligence and data science to speed ...
WEBJun 13, 2012 · Paul Hudson. CEO, Sanofi. “Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions.
Paul Hudson (Chief Executive Officer) - Sanofi
WEBPaul Hudson is reshaping Sanofi into a modern healthcare company with the ambition to transform the practice of medicine. Paul and the Sanofi teams are focusing efforts to discover, develop, manufacture, and make accessible breakthrough medicines and vaccines for people around the world.
Skip to content